Sunday, June 1, 2025

Latest

Biopharmaceutical Firm DICE Therapeutics Prices Upsized US$204 Million IPO

Biopharmaceutical company DICE Therapeutics, Inc. (Nasdaq: DICE) started publicly trading on the Nasdaq Global Market yesterday under the symbol “DICE”. The firm’s initial public offering is looking to raise US$204.0 million and is expected to close on September 17, 2021.

The offering will be conducted through the issuance of 12.0 million common shares selling at US$17.00 per share. This is an adjustment from the company’s original plan to issue 10.0 million shares with share price expectations between US$15.00 and US$17.00.

The company granted the underwriters a 30-day over-allotment option to purchase additional 1.8 million common shares at the same IPO price, potentially bringing proceeds up to US$82.8 million. BofA Securities, SVB Leerink, and Evercore ISI are all acting as joint bookrunners for the said offering.

The California-based biotech firm is in the business of developing immunotherapies for patients with chronic diseases. Currently, the firm’s lead therapeutic candidate S011806 is an oral antagonist targeting a pro-inflammatory signaling molecule connected with a variety of immunology indications. The orally-available candidate is expected to enter its phase 1 trial in the second half of 2021.


Information for this briefing was found via Sedar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Leave a Reply

Video Articles

Alamos Gold Q1 Earnings: The Inside Scoop

Cerrado Gold Q4 Earnings: The Turnaround is Working

B2GOLD Q1 Earnings: Revenue Up, Production & Cash Flow Decline

Recommended

Canadian Copper: The $172M Combined Strategy PEA

ESGold Begins Concentration Tests Ahead Of First Production

Related News

Small-Cap IPOs That Are Pump-And-Dumps Are On The Rise, Thanks To Chinese Firms

The Financial Industry Regulatory Authority Inc. (FINRA) cautions that initial public offerings (IPOs) by international...

Saturday, November 19, 2022, 11:11:00 AM

Renewable Energy SPAC Enphys Acquisition Prices Upsized US$300 Million IPO

Blank check company Enphys Acquisition Corp. (Nasdaq: NFYS.U) went public today on the Nasdaq Global...

Wednesday, October 6, 2021, 02:26:00 PM

Ecommerce Firm GigaCloud Soars 206% Since US$36 Million Nasdaq IPO

B2B ecommerce solutions provider GigaCloud Technology Inc (Nasdaq: GCT) started trading on the Nasdaq Capital...

Monday, August 22, 2022, 02:41:00 PM

Electric Vehicle Maker Phoenix Motorcars Bats For Nasdaq IPO

Phoenix Motor Inc. is looking to join the list of electric vehicle manufacturers going public....

Monday, November 29, 2021, 02:10:00 PM

Clean Transition SPAC Monterey Capital Acquisition Prices Downsized US$80 Million IPO

Special purpose acquisition company Monterey Capital Acquisition Corporation (Nasdaq: MCACU) started trading its securities on...

Wednesday, May 11, 2022, 02:19:00 PM